Karyopharm Announces FDA Approval of XPOVIO® (selinexor) for the Treatment of Patients with Relapsed or Refractory
Karyopharm Therapeutics Angeforderte Firma
Karyopharm is an innovation-driven pharmaceutical company whose core technology leverages the inhibition of nuclear export as a mechanism to treat patients with cancer and other medical conditions Weiterlesen
Excellent medical, dental, and vision coverage.
Was macht Sie bei der Arbeit am glücklichsten?
Celebrating success achieved as a team.
Was sind einige der besten Dinge an Ihrem Team?
We all work hard together to meet deadlines and help patients.
Was gefällt dir am besten am Führungsteam?
The leadership team is connected to everyone, not isolated in a board room.
Other Employee Reviews for Karyopharm Therapeutics
×